Showing results (211-220 of 317) with videos related to
Sort By:
Pageof 32
JCO Precision Oncology|September 11, 2020
CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupLata Chauhan, Miyoung Shin, Yi-Cheng Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2015
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupGeorge S Laszlo, Todd A Alonzo, Chelsea J Gudgeon, et al.Pediatric Blood & Cancer|July 1, 2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology GroupTerzah M Horton, John P Perentesis, Alan S Gamis, et al.JCO Oncology Practice|January 9, 2024
Population-Based Data Linkage Describing Patterns of Cancer Clinical Trial Enrollment Among Children and AdolescentsDavid A Siegel, Eric B Durbin, Brad H Pollock, et al.Journal of Hematology & Oncology|September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyDenise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.Pediatric Blood & Cancer|June 18, 2011
A phase II study of amifostine in children with myelodysplastic syndrome: a report from the Children's Oncology Group study (AAML0121)Prasad Mathew, Robert Gerbing, Todd A Alonzo, et al.Cancer|March 7, 2012
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology GroupApril D Sorrell, Todd A Alonzo, Joanne M Hilden, et al.Cancer|July 19, 2011
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology GroupTodd M Cooper, Janet Franklin, Robert B Gerbing, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2017
Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Michael R Loken, et al.Pediatric Blood & Cancer|March 11, 2021
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemiaMaureen M O'Brien, Todd A Alonzo, Todd M Cooper, et al.Pageof 32